INTRODUCTION
============

Bovine respiratory disease (**BRD**) is considered to be one of the most economically important diseases affecting feedlot cattle ([@r5]). Despite attempts to reduce the morbidity and mortality of the disease through management practices and vaccination programs, little progress has been made to lower the incidence of disease ([@r19]). In U.S. feedlot cattle, the prevalence of clinical BRD has been shown to vary between 5 and 44% across a 15-yr period ([@r17]). This variability is potentially due to environmental factors such as stocking density and climate ([@r17]). Unlike clinical BRD, the prevalence of subclinical BRD has not been well documented. However, it has been suggested that subclinical BRD infection is common, primarily because the correlation of lung lesions in harvested cattle with cattle diagnosed with BRD is low ([@r5]). Common findings at harvest include lung consolidation, in which the lung alveoli are filled with fluid or tissue, and the presence of interstitial fibrinous connective tissue that can lead to fibrosis. These lesions can significantly impact cattle performance in the feedlot by lowering ADG, carcass quality, and HCW ([@r2]). Previous studies have identified loci associated with severe lung lesions and have investigated the effects of lung lesions on growth and carcass traits, but the impact of pathogens on the prevalence of lung lesions at slaughter has not been fully explored ([@r9]). The objectives of this study were to identify host loci associated with the presence of lung consolidation and lung lesions (consolidation and fibrin) and to evaluate the relationship between BRD pathogens and lung lesion prevalence in feedlot cattle.

MATERIALS AND METHODS
=====================

All animal care and sample collections were approved and performed in accordance with the Institutional Animal Care and Use Committee at Washington State University (04110).

Study Population
----------------

The study population consisted of 999 steers from a commercial feedlot, with a 1-time capacity of 98,000 cattle, located in Kersey, CO. The commercial *Bos taurus* steers were enrolled in the study between August 2012 and May 2013 and had been identified as Angus (*n* = 909), Red Angus (*n* = 45), Hereford (*n* = 25), Charolais (*n* = 19), or crossbreeds (*n* = 1). Steers were vaccinated on entry into the feedlot but did not receive prophylactic antibiotics. Cattle were evaluated for signs of BRD (temperature, cough, nasal discharge, eye discharge, and ear tilt) and classified as cases or controls based on the McGuirk scoring system ([@r12]). Cattle that died before harvest or that had no recorded lung score data (*n* = 79) were removed from the analysis.

Lung Scoring
------------

Lung lesions were scored using a modified version of the [@r2] protocol described by [@r18]. Briefly, on evisceration, lungs were manually palpated and evaluated for presence and severity of lung lesions, and any additional abnormalities (hyperinflated lungs, missing lung lobes, etc.) were noted. Lungs were independently scored based on the amount of lung consolidation (**LC**) present (0 = \<5% consolidation, *n* = 512; 1 = 5--15% consolidation, *n* = 165; 2 = 15--50% consolidation, *n* = 167; and 3 = \>50% consolidation, *n* = 76) and the presence and severity of fibrin tissue in the lung (**FT**; NFT = normal or no fibrin tissue, *n* = 436; M = minor amounts of fibrin, *n* = 186; and E = extensive fibrin in the lungs, *n* = 298). Animals that had both LC and FT damage to their lungs were given a combined lung lesion (**LL**) score reflecting the scores for both LC and FT (i.e., 1E). This resulted in a combined phenotype: 0NFT (*n* = 290), 0M (*n* = 101), 0E (*n* = 121), 1NFT (*n* = 62), 1M (*n* = 43), 1E (*n* = 60), 2NFT (*n* = 55), 2M (*n* = 34), 2E (*n* = 78), 3NFT (*n* = 29), 3M (*n* = 8), and 3E (*n* = 39). We also determined whether a lung was hyperinflated (hyperinflated lungs \[**HIF**\]; INF = inflated, *n* = 37) or not (NIF **=** normal; *n* = 892) at harvest.

Pathogen Profiles
-----------------

One deep pharyngeal and 1 mid-nasal swab were collected per animal for viral quantitative PCR (**qPCR**) detection, and a second deep pharyngeal swab was collected for the culturing of aerobic bacteria and mycoplasma ([@r16]). Bacterial samples were submitted to the Washington Animal Disease Diagnostic Laboratory at Washington State University (Pullman, WA) and viral samples were submitted to the California Animal Health and Food Safety Lab System (Davis, CA). *Trueperella pyogenes*, *Histophilus somni*, *Mannheimia haemolytica*, *Pasteurella multocida*, and *Mycoplasma* species were detected by culture, and bovine corona virus, bovine viral diarrhea virus, bovine herpes virus type 1 (**BHV-1**), and bovine respiratory syncytial virus were detected by qPCR. The presence or absence of pathogens was evaluated with the presence (*n* = 408) or absence (*n* = 512) of LC, the presence (*n* = 484) or absence (*n* = 436) of FT, the presence (*n* = 630) or absence (*n* = 290) of LL, or the presence (*n* = 37) or absence (*n* = 883) of HIF at harvest.

Quality Control
---------------

Bovine DNA was isolated from whole blood using a Puregene DNA extraction kit following the manufacturer\'s guidelines (Qiagen, Germantown, MD). Samples were quantified using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific Inc., Wilmington, DE) and genotyped using the Illumina BovineHD BeadChip (Neogen Corp., Lincoln, NE; *n* = 777,962 SNP). The positions of the SNP within the bovine reference genome and their alleles were assigned using the forward strand of the UMD 3.1 reference genome (<http://bovinegenome.org/?q=node/61>; accessed 11 August 2016).

Before genomewide association analysis (**GWAA**), samples were filtered by call rate (\<0.90), which resulted in the removal of 59 samples. The SNP were also removed if marker call rate was \<90% (*n* = 33,024), if the minor allele frequency was \<1% (*n* = 27,380), or if they deviated from Hardy--Weinberg equilibrium (*P* \< 10^−75^; *n* = 28,631). After quality control filtering, 861 samples and 688,928 SNP remained for the GWAA.

Statistical Analysis
--------------------

The estimated odds ratio (**OR**) and the 95% confidence interval were individually computed for each BRD pathogen tested by culture (*Trueperella pyogenes*, *Histophilus somni*, *Mannheimia haemolytica*, *Pasteurella multocida*, and *Mycoplasma* species) or by qPCR (bovine corona virus, bovine viral diarrhea virus, BHV-1, and bovine respiratory syncytial virus) and its association with LL, LC, FT, and HIF. A 2-tailed Fisher\'s exact test was used to determine if the OR was significant (*P* \< 0.05) as previously described ([@r14]). The GWAA were performed using an efficient mixed-model association eXpedited with a genomic relationship matrix (EMMAX-GRM) additive genotypic model as part of the SNP and Variation Suite version 8 (**SVS**; Golden Helix, Inc., Bozeman, MT; [http://goldenhelix.com](http://goldenhelix.com/)). The general mixed model can be defined as **y**c = c**Xβ** + c**Z***u*c + ϵ, in which **y** is an *n*c × c1 vector of the observed phenotypes, **X** is a *n*c × c*q* incidence matrix relating observations to levels of fixed effects, β is a *q*c × c1 vector representing the levels of the fixed effects, and **Z** is a *n*c × c*t* matrix relating the instances of the random effect to the observations. Residuals were estimated based on maximum likelihood parameters and are assumed to be independent and identically distributed ([@r8]). In this study, we assumed that Var(*u*) = σ^2^g**K** and Var(ϵ) = σ^2^~e~**INF**, such that Var(γ) = σ^2^~g~**ZKZ′** + σ^2^~e~**INF**, in which **K** is the matrix of pairwise genomic relationships and **Z** is the identity matrix **INF**. Each GWAA included breed as a fixed effect. Using SVS, pseudoheritability estimates were calculated as *h*^2^ = σ^2^~a~/(σ^2^~a~ + σ^2^~e~) ([@r8]). The [@r22] thresholds for unadjusted *P*-values were used to determine if there was evidence of an association between the phenotype and each SNP. Using these thresholds, QTL were identified by SNP that were moderately (5 × 10^−7^ \> *P* \< 1 × 10^−5^) or strongly associated (*P* \< 5 × 10^−7^) with the phenotype. Any SNP in linkage disequilibrium (*r*^2^ \> 0.9) with the lead SNP was considered to constitute the same QTL as the lead SNP. A 24-kb region (12 kb 5′ to 12 kb 3′), based on the average haplotype block size (12,703 bp) for the cattle in the study, was investigated for each associated SNP to identify positional candidate genes. Haplotype blocks were estimated in SVS following the method described by [@r4] using a SNP allele correlation of \>0.9.

RESULTS AND DISCUSSION
======================

Results of the LC, LL, and HIF pathogen profile comparisons are provided in [Table 1](#tbl1){ref-type="table"}. Pathogen profiles did not vary in the FT comparison, so these data are not presented. Of the 9 tested pathogens, BHV-1, the causative agent for infectious bovine rhinotracheitis ([@r23]), was more common in cattle with LC (OR = 3.37, *P* = 0.012) and LL (OR = 4.58, *P* = 0.041). During a BHV-1 infection, lesions form along the respiratory tract extending from the nostrils to the bronchi ([@r24]). Tracheitis associated with the infection can spread into the lungs causing epithelial cells to be shed into the airways leading to fibrinous exudate formation, which may explain its high frequency in LC and LL cattle ([@r24]).

###### 

Pathogens identified from deep pharyngeal and mid-nasal swabs in Colorado feedlot steers

                              Prevalence^2^   Odds ratio^3^   95% confidence interval^4^   Odds ratio, *P*-value^5^                                                                                   
  -------------------------- --------------- --------------- ---------------------------- -------------------------- ------ ------ -------------- --------------- --------------- --------- --------- ---------
  *Trueperella pyogenes*        1.4 (2.5)       1.4 (2.1)             2.1 (2.7)                      1.83             1.52   1.49   0.69 to 4.84   0.49 to 4.69    0.19 to 11.57    0.23      0.47      0.70
  *Histophilus somni*          19.7 (18.9)     18.7 (19.9)           19.8 (16.2)                     0.96             1.08   0.79   0.69 to 1.33   0.76 to 1.54    0.33 to 1.93     0.79      0.67      0.61
  *Mannheimia haemolytica*     30.1 (28.4)     30.1 (29.3)           30.3 (29.7)                     0.93             0.96   1.01   0.70 to 1.24   0.71 to 1.31    0.49 to 2.07     0.64      0.81      0.98
  *Pasteurella multocida*      35.0 (38.0)     35.3 (37.2)           36.1 (40.5)                     1.16             1.09   1.19   0.88 to 1.52   0.81 to 1.45    0.61 to 2.33     0.30      0.58      0.61
  *Mycoplasma* spp.            82.6 (78.4)     83.8 (79.4)           80.9 (94.6)                     0.77             0.74   4.33   0.55 to 1.06   0.52 to 1.07    1.03 to 18.16    0.11      0.11     0.04^6^
  BCV                          12.7 (12.5)     11.7 (14.7)            13.6 (8.1)                     0.96             1.30   0.71   0.65 to 1.42   0.83 to 2.01    0.21 to 2.40     0.83      0.25      0.59
  BVDV                          3.1 (2.2)       4.1 (2.4)             3.0 (2.7)                      0.74             0.59   0.99   0.32 to 1.69   0.26 to 1.31    0.13 to 7.60     0.47      0.20      0.99
  BHV-1                         1.2 (3.9)       0.7 (3.3)             2.3 (5.4)                      3.37             4.58   2.67   1.31 to 8.69   1.06 to 19.72   0.60 to 11.95   0.01^6^   0.04^6^    0.20
  BRSV                          1.2 (1.0)       1.4 (1.0)             1.5 (2.7)                      0.84             0.69   2.71   0.24 to 2.99   0.19 to 2.46    0.33 to 22.02    0.79      0.57      0.35

^1^BCV = bovine corona virus; BVDV = bovine viral diarrhea virus; BHV-1 = bovine herpes virus type 1; BRSV = bovine respiratory syncytial virus.

^2^Prevalence of each pathogen is listed for each phenotype in separate columns: lung consolidation (LC), lung lesions (LL), and hyperinflated lungs (HIF). The percent of normal lungs and lungs affected (in parentheses) with LC, LL, or HIF are shown. Animals classified as indeterminate with respect to each pathogen were not included in the summary statistics.

^3^Odds ratio of being affected with LC, LL, and HIF when the diagnostic swab was positive for that pathogen.

^4^95% confidence interval for the odds ratio of being affected with LC, LL, or HIF.

^5^Odds ratio significance value associated with being affected with LC, LL, or HIF when the diagnostic swab was positive for that pathogen.

^6^Pathogen prevalence differs significantly (*P* \< 0.05).

In cattle with HIF, of the tested BRD pathogens, *Mycoplasma* spp. was more commonly found (OR = 4.33, *P* = 0.045). Hyperinflated lungs have been reported in cattle that have previously experienced pulmonary damage caused by infections, especially from the BRD pathogens BHV-1, *Pasteurella multocida*, and *Mycoplasma* spp. ([@r13]). *Mycoplasma* spp. infections have been shown to cause lung abnormalities and permanent lung damage in the months to years following the resolution of the initial infection in humans ([@r20]). Similar results were observed in mice, where *Mycoplasma pneumoniae*--exposed mice had increased pulmonary inflammation and obstruction compared with control mice 530 d after infection ([@r6]).

Five QTL were identified as associated in the LC GWAA ([Table 2](#tbl2){ref-type="table"}). The most significant lead SNP (*rs109299286*) was located on a contig that has not been assigned to a bovine chromosome. Another QTL was located on BTA14 and was identified by a lead SNP (*rs135662870*) within an intron of *neurocalcin delta* (*NCALD*). A third QTL, located on BTA11, was identified by a lead SNP (*rs134730725*) located within an intron of *mitogen-activated protein kinase associated protein 1* (*MAPKAP1*). The remaining 2 QTL were located within intergenic regions on BTA18 (*rs136844537*) and BTA20 (*rs135580824*). The pseudoheritability estimate for LC was 0.25. The pseudoheritability estimate for FT was 0.00, although when fibrin scores were combined with LC scores, the pseudoheritability estimate for LL was 0.28.

###### 

Quantitative trait loci identified in the genomewide association analyses for the presence or absence of lung consolidation (LC), lung lesions (LL), or hyperinflated lungs (HIF) in 920 Colorado feedlot steers

  Chromosome (location in Mb)^1^    Lead SNP (no. SNP)^2^     Phenotype     *P*-value of lead SNP^3^    Positional candidate genes^4^
  -------------------------------- ----------------------- --------------- -------------------------- ---------------------------------
  unassigned                          *rs109299286* (1)          LC              2.87 × 10^−6^                       NA
  1 (49--50)                          *rs136506519* (1)          HIF             2.86 × 10^−6^                       --
  2 (54--55)                          *rs133243829* (1)          HIF             3.01 × 10^−6^                       --
  3 (112--113)                        *rs43365726* (1)           HIF             3.83 × 10^−10^                      --
  4 (102--103)^5^                     *rs137372462* (1)          HIF             7.72 × 10^−6^                       --
  4 (102--103)^5^                     *rs135680653* (1)          HIF             1.64 × 10^−6^                  ***CREB3L2***
  4 (102--103)^5^                     *rs136731537* (5)          HIF             2.33 × 10^−7^                  ***AKR1D1***
  4 (102--103)^5^                     *rs133846461* (1)          HIF             9.54 × 10^−6^                       --
  4 (102--103)^5^                     *rs135535135* (1)          HIF             1.44 × 10^−6^                       --
  4 (102--103)^5^                     *rs137634412* (1)          HIF             8.50 × 10^−6^                       --
  5 (30--31)                          *rs133157293* (2)          HIF             2.64 × 10^−6^            ***TUBA1A*** and *TUBA1B*
  6 (72--73)                          *rs109673399* (1)          HIF             2.38 × 10^−6^                    ***KDR***
  8 (0--1)                            *rs133944973* (5)          HIF             2.55 × 10^−8^                  ***ANXA10***
  8 (81--82)                          *rs134212138* (1)          LL              5.55 × 10^−6^                       --
  11 (0--1)                           *rs134761437* (1)          HIF             4.73 × 10^−6^              *ENSBTAG00000038257*
  11 (96--97)                         *rs134730725* (1)          LC              9.98 × 10^−6^                  ***MAPKAP1***
  14 (64--65)                         *rs135662870* (2)          LC              4.13 × 10^−6^                   ***NCALD***
  *rs110429664* (4)                          LL             4.24 × 10^−6^                             
  15 (47--48)                         *rs135937397* (1)          HIF             7.02 × 10^−6^         ***APBB1*, *HPX*,** and *TRIM3*
  18 (44--45)                         *rs136844537* (1)          LC              7.25 × 10^−6^                       --
  20 (70--71)                         *rs135580824* (1)          LC              6.61 × 10^−6^                       --
  23 (7--8)                           *rs136808471* (1)          HIF             8.34 × 10^−7^             ***ITPR3*** and *IP6K3*
  28 (0--1)                           *rs109312685* (1)          LL              5.87 × 10^−6^                       --

^1^Chromosome location of the QTL followed by the location of SNP in megabases, in parentheses, as measured by numbered nucleotides in the UMD 3.1 reference genome assembly (<http://bovinegenome.org/?q=node/61>; accessed 11 August 2016).

^2^The most significant SNP tagging the QTL was identified by the *rs* number, which is a reference number assigned to markers submitted to the National Center for Biotechnology Information SNP database (<https://www.ncbi.nlm.nih.gov/projects/SNP>/; accessed 1 September 2016). The number of SNP associated with each QTL is listed in parentheses.

^3^Significance (*P*-value) for the SNP with the strongest evidence for an association (lead SNP) with LC, LL or HIF.

^4^NA = Not applicable. Positional candidate genes were defined as genes located within 12 kb on either side of the associated SNP. Bold gene names represent genes where SNP within the QTL are located within an intron of the gene.

^5^Haplotypes defined using the method described by [@r4] and a *r*^2^ \> 0.9 resulted in these being in different haplotype blocks, although loci were located within 351.6 kb from one another.

There were 3 QTL associated with LL ([Table 2](#tbl2){ref-type="table"}). The lead SNP (*rs110429664*) was located on BTA14, within the same region as the QTL within an intron of *NCALD* identified in the LC GWAA identified by the lead SNP *rs135662870*. The other 2 QTL were identified by SNP located within intergenic regions on BTA8 (*rs134212138*) and BTA28 (*rs109312685*).

Fifteen QTL across 10 chromosomes were identified in the HIF GWAA ([Table 2](#tbl2){ref-type="table"}). The most significant QTL was identified by the lead SNP (*rs43365726*) located in an intergenic region on BTA3. Eight of the 12 HIF positional candidate genes had SNP located with their introns, whereas 4 had SNP located in the surrounding intergenic regions. The pseudoheritability estimate for HIF was 0.13.

Several of the positional candidate genes associated with LC, LL, and HIF function in signal transduction. Six of the 15 genes (*cAMP responsive element binding protein 3 like 2* \[*CREB3L2*\], *inositol hexakisphosphate kinase* \[*IP6K3*\], *inositol 1,4,5-triphosphate receptor 3* \[*ITPR3*\], *kinase insert domain receptor* \[*KDR*\], *MAPKAP1*, and *NCALD*) are involved in signal transduction pathways. The involvement of these genes in signal transduction pathways in cattle with BRD is consistent with pathways associated with respiratory disease in humans. Signal transduction pathways are known to have a role in the inflammatory response of respiratory cells of humans affected by bacterial infections ([@r1]), and abnormalities in these pathways can lead to fibrotic disorders and excess inflammatory responses in the lung ([@r10]). Mutations affecting signal transduction could trigger more adverse inflammatory reactions to infections, potentially leading to lung cell damage.

Seven genes associated with LC and HIF (*amyloid β precursor protein binding family B member 1* \[*APBB1*\], *hemopexin* \[*HPX*\], *IP6K3*, *ITPR3*, *KDR*, *tubulin α 1a* \[*TUBA1A*\], and *tubulin α 1b* \[*TUBA1B*\]) are involved in pathways related to adherens junctions and tight junctions through intermediate molecules including epidermal growth factor receptor, interleukin 6, and protein kinase C zeta. Adherens junctions and tight junctions of the respiratory epithelium contribute to the barrier between harmful environmental stimuli and the lung in most animal species including humans ([@r7]). Several families of viruses use cell adhesion components of both adherens junctions and tight junctions, such as E-cadherin, to gain entry into the epithelium ([@r11]). In humans, infection with respiratory syncytial virus has been linked to decreased expression of E-cadherin ([@r21]). In respiratory cells, decreased expression of E-cadherin can lead to cells breaking away from the basal membrane and contributing to LC. Six genes associated with HIF (*IP6K3*, *ITPR3*, *KDR*, *tripartite motif containing 3* \[*TRIM3*\], *TUBA1A*, and *TUBA1B*) are in gap junction pathways. Gap junctions are composed of proteins known as connexins, which form channels on the cell surface to allow communication between connected cells and contribute to surfactant secretion in the lung. Multiple connexins are known to be differentially expressed in response to pulmonary inflammatory diseases in humans including idiopathic pulmonary fibrosis and acute lung inflammation ([@r3]). Additionally, connexins can be regulated by both adherens junction-- and tight junction--associated proteins, and it has been suggested that connexin 40 and connexen 43 are required to work with tight junctions in the lung and brain to maintain the endothelial barrier ([@r15]). Any mutation affecting respiratory cell adhesion or gap junctions could alter lung permeability, allowing pathogens to more easily invade the tissue.

Cattle with subclinical BRD are not identified as ill and therefore not treated for disease. Failure to identify subclinical BRD in cattle is both an animal welfare issue and an economic issue. This study identified QTL associated with subclinical disease through the presence or absence of LC, LL, or HIF in cattle at harvest. There were no overlapping QTL between LC, LL, and HIF, but there was a single QTL on BTA14 that overlapped between LC and LL. Of the 646 (64.7%) cattle with lung abnormalities, only 319 (49.4%) had clinical signs of BRD. The remaining cattle were perceived as healthy, showing few clinical signs of disease. The proportion of the cattle with lung abnormalities was nearly as great in those that appeared to be healthy (69.0%) as in cattle treated for clinical BRD (71.5%). This illustrates the difficulty in accurately identifying cattle with subclinical BRD and the subsequent complexity of identifying QTL associated with enhanced resistance to the disease. This segment of the BRD-susceptible feedlot population has not been well investigated for the identification of QTL associated with the disease ([@r16]). The identification of QTL associated with lung abnormalities can be included with QTL associated with clinical BRD to aid in the selection of cattle that are more resistant to both clinical and subclinical BRD. This will ultimately lower the prevalence of BRD infection, improve animal welfare, and decrease economic losses caused by the disease.

This project was supported by the Agriculture and Food Research Initiative competitive grant number 2011-68004-30367 of the USDA National Institute of Food and Agriculture.

[^1]: The names of the research team members working on the Bovine Respiratory Disease Complex Coordinated Agricultural Project are listed at <http://www.brdcomplex.org>.
